Le Lézard
Classified in: Health, Business
Subject: CON

Comagine Health Selected as Prime Awardee of the Network of Quality Improvement and Innovation Contractor by the Centers for Medicare & Medicaid Services


SALT LAKE CITY, June 14, 2019 /PRNewswire-PRWeb/ -- The Centers for Medicare & Medicaid Services selected Comagine Health as a Prime awardee of the Network of Quality Improvement and Innovation Contractor. As a Prime NQIIC awardee partnering with other Quality Improvement contractors under the new CMS Indefinite Delivery/Indefinite Quantity (IDIQ) contract mechanism to support quality improvement efforts, each NQIIC may serve as:

As a NQIIC awardee, Comagine Health has demonstrated healthcare quality improvement expertise. Services supported by some of the NQIIC awardees may include:

About Comagine Health

Comagine Health, formerly Qualis Health and HealthInsight, works collaboratively with patients, providers, payers and other stakeholders to reimagine, redesign and implement sustainable improvements in the health care system. As a trusted, neutral party, we work in our communities to address key, complex health and health care delivery problems. In all our engagements and initiatives, we draw upon our expertise in quality improvement, care management, health information technology, analytics and research. We invite our partners and communities to work with us to improve health and redesign the health care delivery system. For more information, please visit comagine.org.

 

SOURCE Comagine Health


These press releases may also interest you

at 15:21
Autism Community Ventures, a nonprofit organization dedicated to helping people on the autism spectrum successfully integrate into 21st-century careers, is proud to announce that the inaugural round of transition scholarships for its...

at 12:05
VBI Vaccines Inc. ("VBI"), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, will host a conference call and webcast tomorrow morning, June 17, 2019, at 8:00 AM ET. Management...

at 10:06
Oncopeptides AB  announced today updated interim efficacy and safety data from the ongoing, pivotal Phase 2 HORIZON trial. The oral presentation was included in the "Novel strategies in multiple myeloma" session and was led by Professor Paul G....

at 10:00
OakBend Medical Center has set up the latest technology in telemedicine at its Wharton hospital campus. This innovative way of caring for patients uses a combination of telecommunication and information technology to provide patients clinical health...

at 09:00
Sports recovery device company, PlayMakar Inc. has signed an endorsement deal with Alfonso "Trey" Burke, point guard for the Dallas Mavericks' basketball team. Under the sponsorship terms, Burke will serve as a prominent face for the PlayMakar brand...

at 02:00
AstraZeneca Egypt has been awarded the best place to work in Egypt for 2019 among other employers in Egypt. The annual prestigious Best Places To Work  program recognizes leading employers around the world and provides employers the opportunity to...



News published on 14 june 2019 at 18:00 and distributed by: